Recruiting Cancer Clinical Trials

ETOP Adeppt

A multicentre, single-arm phase II trial of adagrasib in patients with KRAS G12C-mutant NSCLC, including the elderly (≥70 years) or patients with poor performance status.
Description: This is a single arm trial assessing the effectiveness of adagrasib in patients with non-small cell lung cancer that have the KRAS G12C mutation. This trial includes those over 70 years or age or those that have a poor performance status
Study Phase: Phase 3
Principal Investigator: Dr Sinead Cuffe
Further information

Neo-Coast

A Phase 2 Open-label, Multicenter, Randomized, Study of Neoadjuvant and Adjuvant Treatment in Subjects with Resectable, Early-stage (II to IIIA) Non-small Cell Lung Cancer (NeoCOAST-2)
Description: This trial assesses various treatment combinations given in the neoadjuvant (ie before surgery) and adjuvant setting (ie after surgery) in patients with Resectable, Early-stage (II to IIIA) Non-small Cell Lung Cancer
Study Phase: Phase 2
Principal Investigator: Dr Sinead Cuffe
Further information